|
⚲
|
| Keyboard |
| McClure Matthew W
✚
|
|
|---|---|
| CIK # | 0001927121 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001927121] | |
| 4 | [0001927121] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| McClure Matthew W | |
| Aligos Therapeutics Inc |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Aligos Therapeutics Inc ALGS
Stock Option (Right to Buy) · derivative
|
2024-03-01 | Grant | 72,000 | $0.00 | |
|
Aligos Therapeutics Inc ALGS
Stock Option (Right to Buy) · derivative
|
2024-02-28 | Grant | 16,428 | $0.00 | |
|
Aligos Therapeutics Inc ALGS
Stock Option (Right to Buy) · derivative
|
2024-02-28 | Grant | 65,713 | $0.00 | |
|
Aligos Therapeutics Inc ALGS
Stock Option (Right to Buy) · derivative
|
2024-02-28 | Grant | 75,183 | $0.00 | |
|
Aligos Therapeutics Inc ALGS
Stock Option (Right to Buy) · derivative
|
2024-02-27 | Disposed to issuer | 92,000 | $0.00 | |
|
Aligos Therapeutics Inc ALGS
Stock Option (Right to Buy) · derivative
|
2024-02-27 | Disposed to issuer | 23,000 | $0.00 | |
|
Aligos Therapeutics Inc ALGS
Stock Option (Right to Buy) · derivative
|
2024-02-27 | Disposed to issuer | 255,626 | $0.00 | |
|
Aligos Therapeutics Inc ALGS
Stock Option (Right to Buy) · derivative
|
2023-09-08 | Grant | 48,000 | $0.00 | |
|
Aligos Therapeutics Inc ALGS
Stock Option (Right to Buy) · derivative
|
2023-03-15 | Grant | 75,000 | $0.00 | |
|
Aligos Therapeutics Inc ALGS
Stock Option (Right to Buy) · derivative
|
2022-07-07 | Grant | 46,000 | $0.00 |